TY - JOUR
T1 - Signs and symptoms of the postictal period in epilepsy
T2 - A systematic review and meta-analysis
AU - Subota, Ann
AU - Khan, Sundus
AU - Josephson, Colin B.
AU - Manji, Sofiya
AU - Lukmanji, Sara
AU - Roach, Pamela
AU - Wiebe, Samuel
AU - Buchhalter, Jeffrey
AU - Federico, Paolo
AU - Teskey, G. Campbell
AU - Lorenzetti, Diane L.
AU - Jetté, Nathalie
N1 - Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/5
Y1 - 2019/5
N2 - Objective: The postictal period has many physical, behavioral, and cognitive manifestations associated with it. These signs and symptoms are common, can be quite debilitating, and can have a continued impact long after the seizure has ended. The purpose of this systematic review was to quantify the occurrence of postictal signs and symptoms, along with their frequency and duration in persons with epilepsy. Methods: Cochrane Database of Systematic Reviews, CINAHL, EMBASE, MEDLINE, PsycINFO, Web of Science, and Scopus were searched from inception to November 29, 2017. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting standards were followed. Search terms included subject headings and text words such as convulsion, epilepsy, seizure, postictal, post seizure, seizure recovery, seizure end, Todd's paresis, and Todd's paralysis. Standardized forms were used to collect various study variables. Abstract and full-text review, data abstraction, and quality assessment were all done in duplicate. Study heterogeneity was assessed using the I-squared test, and a random effects model was used to determine estimates. Publication bias was evaluated using funnel plots. Results: From 7811 abstracts reviewed, 78 articles met eligibility criteria, with 31 postictal manifestations (signs and/or symptoms) described and 45 studies included in the meta-analysis. The majority of studies described postictal headaches, migraines, and psychoses, with mean weighted frequency of 33.0% [95% confidence interval (CI) 26.0–40.0], 16.0% [95% CI 10.0–22.0], and 4.0% [95% CI 2.0–5.0], respectively. The mean weighted proportions of manifestations ranged from 0.5% (subacute postictal aggression) to 96.2% (postictal unresponsiveness) with symptom duration usually lasting < 24 h but up to 2 months for physical and cognitive/behavioral symptoms respectively. Significance: Examining data on the various signs and symptoms of the postictal period will have practical applications for physicians by raising their awareness about these manifestations and informing them about the importance of optimizing their prevention and treatment in epilepsy.
AB - Objective: The postictal period has many physical, behavioral, and cognitive manifestations associated with it. These signs and symptoms are common, can be quite debilitating, and can have a continued impact long after the seizure has ended. The purpose of this systematic review was to quantify the occurrence of postictal signs and symptoms, along with their frequency and duration in persons with epilepsy. Methods: Cochrane Database of Systematic Reviews, CINAHL, EMBASE, MEDLINE, PsycINFO, Web of Science, and Scopus were searched from inception to November 29, 2017. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting standards were followed. Search terms included subject headings and text words such as convulsion, epilepsy, seizure, postictal, post seizure, seizure recovery, seizure end, Todd's paresis, and Todd's paralysis. Standardized forms were used to collect various study variables. Abstract and full-text review, data abstraction, and quality assessment were all done in duplicate. Study heterogeneity was assessed using the I-squared test, and a random effects model was used to determine estimates. Publication bias was evaluated using funnel plots. Results: From 7811 abstracts reviewed, 78 articles met eligibility criteria, with 31 postictal manifestations (signs and/or symptoms) described and 45 studies included in the meta-analysis. The majority of studies described postictal headaches, migraines, and psychoses, with mean weighted frequency of 33.0% [95% confidence interval (CI) 26.0–40.0], 16.0% [95% CI 10.0–22.0], and 4.0% [95% CI 2.0–5.0], respectively. The mean weighted proportions of manifestations ranged from 0.5% (subacute postictal aggression) to 96.2% (postictal unresponsiveness) with symptom duration usually lasting < 24 h but up to 2 months for physical and cognitive/behavioral symptoms respectively. Significance: Examining data on the various signs and symptoms of the postictal period will have practical applications for physicians by raising their awareness about these manifestations and informing them about the importance of optimizing their prevention and treatment in epilepsy.
KW - Headache
KW - Migraine
KW - Postictal
KW - Psychosis
KW - Seizure
UR - http://www.scopus.com/inward/record.url?scp=85063988932&partnerID=8YFLogxK
U2 - 10.1016/j.yebeh.2019.03.014
DO - 10.1016/j.yebeh.2019.03.014
M3 - Review article
C2 - 30978637
AN - SCOPUS:85063988932
SN - 1525-5050
VL - 94
SP - 243
EP - 251
JO - Epilepsy and Behavior
JF - Epilepsy and Behavior
ER -